Budapest Post

Cum Deo pro Patria et Libertate
Budapest, Europe and world news

Pfizer says third dose of vaccine is "probably" necessary

Pfizer says third dose of vaccine is "probably" necessary

As of yet, it is unknown for how long Pfizer vaccines protect against COVID-19, given the short-lived path of this product.
The CEO of the pharmaceutical company Pfizer, Albert Bourla, assured that a third booster dose of the COVID-19 vaccine is "probably" necessary within 12 months after being fully vaccinated, for the immunization to be complete.

"It is extremely important to suppress the group of people who may be susceptible to the virus," Bourla told CNBC television in a statement released Thursday.

The executive also indicated that these doses will be an important tool to fight against the variants of COVID-19 that have proven to be more contagious (and making the pharmaceutical companies, again, richer and richer).

So far, it is unknown for how long vaccines protect against COVID-19, given the short haul of this product.

Pfizer recently reported that its COVID-19 vaccine was more than 91% effective against the virus and more than 95% effective against severe symptoms of the disease and that this protection was maintained for at least six months after receiving the first dose.

Likewise, people who receive Moderna's COVID-19 vaccine, which is similar in composition to Pfizer's, continue to show high levels of antibodies six months after the second dose, according to a study published in the scientific journal The New England Journal of Medicine. earlier this month.

The study released by Pfizer showed that its vaccine appears to work similarly against the majority variant of the virus in South Africa, one of the countries where the product was tested.

Pharmaceutical Pfizer announced on February 26 that it would study the possibility of injecting a third dose to vaccinated people to try to strengthen protection against the most aggressive variants of the coronavirus.

Bourla said then that with this third dose the antibody response could be strengthened between 10 and 20 times and stressed that just as people are vaccinated annually against the flu, they will have to do it against covid-19 to be protected.

This new study is aimed at two age groups, people between 65 and 85 years and those between 18 and 55 and will be chosen from the group that already participated in the first trials carried out by the pharmaceutical company Pfizer in cooperation with BioNTech.

The University of Oxford has started a new clinical study to determine if doses of the vaccines can be combined and obtain an adequate immune response with two doses regardless of the manufacturer.

The researchers already have the participation of the vaccine from AstraZeneca, Pfizer, Moderna and the American candidate Novavax.
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
Newsletter

Related Articles

0:00
0:00
Close
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
House Republicans Move to Defund OECD Over Global Tax Dispute
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
Intel Reports Revenue Beats but Sees 81% Rise in Losses
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
President Trump Diagnosed with Chronic Venous Insufficiency After Leg Swelling
CEO Resigns Amid Controversy Over Relationship with HR Executive
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
Tulsi Gabbard Unveils Evidence Alleging Political Manipulation of Intelligence During Trump Administration
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Trump Announces Coca-Cola to Shift to Cane Sugar in U.S. Production
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Air India Pilot’s Mental Health Records Under Scrutiny
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
Moonshot AI Unveils Kimi K2: A New Open-Source AI Model
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Bitcoin Reaches New Milestone of $116,000
Severe Heatwave Claims 2,300 Lives Across Europe
Declining Beer Consumption Signals Cultural Shift in Germany
Emails Leaked: How Passenger Luggage Became a Side Income for Airport Workers
Polish MEP: “Dear Leftists - China is laughing at you, Russia is laughing, India is laughing”
Western Europe Records Hottest June on Record
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
China’s Central Bank Consults European Peers on Low-Rate Strategies
France Requests Airlines to Cut Flights at Paris Airports Amid Planned Air Traffic Controller Strike
Poland Implements Border Checks Amid Growing Migration Tensions
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
×